Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Baloglu
Next-Generation XPO1 Inhibitor Shows Improved Efficacy and in Vivo Tolerability in Hematological Malignancies
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Next Generation XPO1 Inhibitor Shows Improved Efficacy and in Vivo Tolerability in Hematologic Malignancies
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Minimal Residual Disease Monitoring With Next-Generation Sequencing Methodologies in Hematological Malignancies
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Improved Outcome of Critically Ill Patients With Hematological Malignancies: What’s Next?
Intensive Care Medicine
Critical Care
Intensive Care Medicine
Ih2 Inhibition Enhances Proteasome Inhibitor Responsiveness in Hematological Malignancies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Improved Efficacy of a Next-Generation ERT in Murine Pompe Disease
JCI insight
Medicine
A Selective FLT3 Inhibitor Shows Clinical Efficacy in AML
Cancer Discovery
Oncology
In Vivo Cellular Reprogramming: The Next Generation
Cell
Biochemistry
Genetics
Molecular Biology
Telomerase Activation in Hematological Malignancies
Genes
Genetics
Bridging the Gap in Hematological Malignancies
Expert Review of Hematology
Hematology